SYDNEY, AUSTRALIA--(Marketwired - Jan. 22, 2016) - Simavita Limited (ASX:SVA) (TSX VENTURE:SV) ("Simavita" or the "Company") is pleased to confirm that the Security Purchase Plan (SPP) offer has opened today. The SPP offer document and sample application form will be released separately.

The Company is also discussing with existing and potential investors in relation to a potential placement of CDIs in addition to the closing of the first tranche of the private placement offering.

In accordance with paragraph 7(f)(ii) of ASIC Class Order 09/425 (CO 09/425), Simavita Limited (ASX: SVA) gives notice that:

  1. Simavita Limited (the Company) will make offers to issue CHESS Depositary Interests (CDIs) under a Security Purchase Plan (SPP) without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (the Act);
  1. this notice is given in accordance with CO 09/425 and in particular, paragraph 7(f)(ii) of CO 09/425 which requires the Company to give this notice to ASX within the 24 hour period before the SPP offer;
  1. as at January 22 2016, the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and
  1. as at January 22 2016, there is no information:
  1. that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and
  1. that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:
  1. the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or
  1. the rights and liabilities attaching to the CDIs.

For further information, please check our website (

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit

The TSX Venture Exchange ("TSX-V") has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this Release.

Contact Information:

Philippa Lewis, Chief Executive Officer
+61 2 8405 6381

Media and Investor Relations
Glen Zurcher
+61 420 249 299